BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹4,613 Cr | ₹4,102 Cr | ₹3,985 Cr | ₹2,588 Cr | ₹3,420 Cr |
What is the latest Capital Work in Progress ratio of BIOCON ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹4,613 Cr |
| Mar2025 | ₹4,102 Cr |
| Mar2024 | ₹3,985 Cr |
| Mar2023 | ₹2,588 Cr |
| Mar2022 | ₹3,420 Cr |
How is Capital Work in Progress of BIOCON Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,613 Cr | 12.46 | |
| Mar2025 | ₹4,102 Cr | 2.92 | |
| Mar2024 | ₹3,985 Cr | 54.02 | |
| Mar2023 | ₹2,588 Cr | -24.35 | |
| Mar2022 | ₹3,420 Cr | - | |
Compare Capital Work in Progress of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹62,743.5 Cr | -1.5% | -7.1% | 4.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.5% |
-7.1% |
4.1% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses